Products - Oesophageal cancer | Topic | NICE

Showing 4 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Pembrolizumab with chemotherapy and surgery for treating resectable gastric or gastro-oesophageal junction cancer [ID2696]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Nivolumab with ipilimumab for untreated unresectable metastatic oesophageal squamous cell carcinoma ID1629
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy [ID4070]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Zolbetuximab with chemotherapy for untreated claudin 18.2-positive HER2 negative unresectable advanced gastric or gastro-oesophageal junction adenocarcinoma [ID5123]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC